Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | NSD2 | O96028 | 1/20 | 0.41 |
| ▸ | TTR | P02766 | 1/20 | 0.41 |
| ▸ | TDP2 | O95551 | 1/20 | 0.40 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.40 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.40 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | PTPRC | P08575 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18196031 | 0.89 | KDM4E (0.37) | MAPTKDM4EMAPK1HTTSMN1; SMN2 | |
| SCHEMBL18196042 | 0.89 | RAB9A (0.43) | TP53SMN1; SMN2NPC1RAB9AHPGD | |
| SCHEMBL14535554 | 0.81 | — | — | |
| SCHEMBL18425800 | 0.66 | TP53 (0.41) | MAPTKDM4EMAPK1TP53HTT | |
| SCHEMBL8102486 | 0.64 | TDP2 (0.54) | MAPTKDM4EMAPK1TP53HTT | |
| SCHEMBL4273237 | 0.64 | TP53 (0.39) | MAPTKDM4EMAPK1TP53HTT | |
| SCHEMBL9888 | 0.63 | ALDH1A1 (0.86) | MAPTTP53HTTSMN1; SMN2NPC1 | |
| SCHEMBL3783662 | 0.63 | MAPT (0.45) | MAPTKDM4EMAPK1TP53HTT | |
| Hydrochloric Acid SCHEMBL23062930 | 0.62 | ALDH1A1 (0.83) | MAPTTP53HTTSMN1; SMN2NPC1 | |
| SCHEMBL10975643 | 0.62 | F2R (0.73) | MAPTTP53RAB9AALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070110680-A1 | Methods and compositions for controlling biofilm development | MONTANA STATE UNIVERSITY (US) | 2007-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070110680-A1 | Methods and compositions for controlling biofilm development | VCL, BLVRB, DBNL | MAPT 4709/4885KDM4E 1671/4885MAPK1 4587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.